 |
|
Cognitive Domain Decline in Healthy Apolipoprotein E  4 Homozygotes Before the Diagnosis of Mild Cognitive Impairment
Richard J. Caselli, MD;
Eric M. Reiman, MD;
Dona E. C. Locke, PhD;
Michael L. Hutton, PhD;
Joseph G. Hentz, MS;
Charlene Hoffman-Snyder, RN, CNP;
Bryan K. Woodruff, MD;
Gene E. Alexander, PhD;
David Osborne, PhD
Arch Neurol. 2007;64(9):1306-1311.
Background Memory declines more rapidly with age in apolipoprotein E (APOE)  4 carriers than in APOE 4 noncarriers, and APOE 4 homozygotes' cognitive performances correlate with stressors. These changes could represent presymptomatic disease in some, despite their youth.
Objective To show that presymptomatic APOE 4 homozygotes experience greater psychometric decline at a younger age than APOE 4 heterozygotes and noncarriers before the diagnosis of mild cognitive impairment (MCI) and Alzheimer disease (AD).
Design Prospective observational study
Setting Academic medical center.
Participants A total of 43 APOE 4 homozygotes, 59 APOE 4 heterozygotes, and 112 APOE 4 noncarriers aged 50 to 69 years were cognitively healthy and matched at entry according to age, educational level, and sex.
Intervention Neuropsychological battery given every 2 years.
Main Outcome Measures Predefined test and cognitive domain decline criteria applied to consecutive epochs.
Results Of 214 participants, 48 showed no decline on any test, 126 showed decline on only 1 test in 1 or more domains, and 40 showed decline on 2 or more tests in 1 or more domains. Cognitive domain decline occurred in 4 of 10 APOE 4 homozygotes 60 years and older at entry (40.0%) compared with 5 of 66 APOE 4 heterozygotes and noncarriers (7.6%) (P = .02) and was more predictive of subsequent decline than nondomain decline (17 of 24 [70.8%] vs 29 of 70 [41.4%]; P = .01). Decline on any memory test was predictive of further decline (P < .001), as was memory domain decline (P = .006) in all genetic subgroups. Seven participants developed MCI (in 6) or AD (in 1), of whom 5 were APOE 4 homozygotes (P = .008). Retrospective comparison showed that those who experienced multidomain, memory, and language domain decline had lower spatial and memory scores at entry than those who experienced no decline.
Conclusions APOE 4 homozygotes in their 60s have higher rates of cognitive domain decline than APOE 4 heterozygotes or noncarriers before the diagnosis of MCI and AD, thus confirming and characterizing the existence of a pre-MCI state in this genetic subset.
Author Affiliations: Departments of Neurology (Drs Caselli and Woodruff and Ms Hoffman-Snyder), Psychology and Psychiatry (Drs Locke and Osborne), and Biostatistics (Mr Hentz), Mayo Clinic, Scottsdale, Arizona; Department of Psychiatry, University of Arizona, Tucson (Dr Reiman); Department of Psychology, Arizona State University, Tempe (Dr Alexander); Department of Neuroscience, Mayo Clinic, Jacksonville, Florida (Dr Hutton); and the Arizona Alzheimer's Disease Research Consortium, Maricopa County, Arizona (Drs Caselli, Reiman, Locke, Woodruff, Alexander, and Osborne and Ms Hoffman-Snyder).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles
Bennett et al.
Neurology 2009;72:1495-1503.
ABSTRACT
| FULL TEXT
Correlating Cerebral Hypometabolism With Future Memory Decline in Subsequent Converters to Amnestic Pre-Mild Cognitive Impairment
Caselli et al.
Arch Neurol 2008;65:1231-1236.
ABSTRACT
| FULL TEXT
|
